Labeler
Alnylam Pharmaceuticals, Inc. NDC Codes
Alnylam Pharmaceuticals, Inc. lists 4 finished drug products in the FDA NDC Directory under NDC labeler code 71336.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Active ingredients
- Vutrisiran sodium, Lumasiran sodium, Givosiran sodium, Patisiran sodium
- NDC labeler codes
- 71336
- Strengths
- Vutrisiran sodium 25 mg/.5mL; Lumasiran sodium 94.5 mg/.5mL; Givosiran sodium 189 mg/mL; Patisiran sodium 2 mg/mL
- Dosage forms
- Injection, Solution, Injection, Injection, Lipid complex
- Routes
- Subcutaneous, Intravenous
- Drug classes (FDA established)
- Small Interfering RNA, Transthyretin-directed RNA Interaction, Aminolevulinate Synthase 1-directed RNA Interaction
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 4
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Amvuttravutrisiran | Vutrisiran sodium 25 mg/.5mL | InjectionSubcutaneous | 71336-1003 | 71336-1003-01 | — |
| Oxlumolumasiran | Lumasiran sodium 94.5 mg/.5mL | Injection, SolutionSubcutaneous | 71336-1002 | 71336-1002-01 | — |
| Givlaarigivosiran sodium | Givosiran sodium 189 mg/mL | Injection, SolutionSubcutaneous | 71336-1001 | 71336-1001-01 | — |
| Onpattropatisiran | Patisiran sodium 2 mg/mL | Injection, Lipid complexIntravenous | 71336-1000 | 71336-1000-01 | — |
Alnylam Pharmaceuticals, Inc.: common questions
- What is Alnylam Pharmaceuticals, Inc.'s NDC labeler code?
- 71336. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Alnylam Pharmaceuticals, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.